CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 12, 2024 -- Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues characterized illnesses identified after presumed cosmetic BoNT injections and examined implicated BoNT products.
The New York City Department of Health and Mental Hygiene identified three patients and the Tennessee Department of Health identified four patients (one a Kentucky resident) with illnesses after presumed cosmetic BoNT injections. The researchers found that all patients were women, aged 26 to 55 years. Ptosis, dry mouth, dysphagia, shortness of breath, and weakness were reported signs and symptoms. Health care was sought by all patients; four were hospitalized and two underwent intensive care unit monitoring. Intubation was not required by any of the patients. Botulinum antitoxin was not required for any of the patients. All patients reported receipt of BoNT injections in nonmedical settings a median of three days prior to onset of symptoms. The three Tennessee residents and Kentucky resident received injections in a nonmedical residential setting; the BoNT product was counterfeit, and the person who administered the injections was not licensed. The three New York City residents received injections in separate nonmedical settings; administration was confirmed to be by an unlicensed person for one resident and suspected for two.
"Health care providers should ask patients with symptoms of botulism about recent BoNT injections and, if botulism is suspected, immediately contact their local or state health departments," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 07:15
Read more
- Online Yoga Classes Can Ease Lower Back Pain
- Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025
- Young Adults Born Preterm Face Economic and Educational Challenges
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
- How a Move Away From Beef Could Help the Planet
- Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions